Retigabine-induced population primary afferent hyperpolarisation in vitro

Neuropharmacology

Volumn 51, Issue 4, 2006, Pages 756-763

  Rivera Arconada, I ^a   Lopez Garcia, J A ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Dorsal root reflexes; KCNQ; Primary afferent fibres; Retigabine; Spinal cord; XE 991

Indexed keywords

10,10 BIS(4 PYRIDINYLMETHYL) 9(10H) ANTHRACENONE; PICROTOXIN; POTASSIUM CHANNEL BLOCKING AGENT; RETIGABINE; TETRODOTOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL ROOT; DORSAL ROOT POTENTIAL; DRUG EFFECT; ELECTRODE; ELECTROSTIMULATION; FEMALE; HYPERPOLARIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; SPINAL CORD;

ACTION POTENTIALS; AFFERENT PATHWAYS; ANIMALS; ANIMALS, NEWBORN; ANTHRACENES; ANTICONVULSANTS; CARBAMATES; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; ELECTRIC STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GABA ANTAGONISTS; GANGLIA, SPINAL; GLUTAMATES; MALE; PHENYLENEDIAMINES; PICROTOXIN; RATS; RATS, WISTAR; SPINAL CORD;

EID: 33748175036     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.05.015     Document Type: Article

References (34)

1. Blackburn-Munro G., and Jensen B.S. The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain. European Journal of Pharmacology 460 (2003) 109-116
2. Brown D.A., and Adams P.R. Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone. Nature 283 (1980) 673-676
3. Brown B.S., and Yu S.P. Modulation and genetic identification of the M channel. Progress in Biophysics and Molecular Biology 73 (2000) 135-166
4. Cervero F., and Laird J.M. Mechanisms of touch-evoked pain (allodynia): a new model. Pain 68 (1996) 13-23
5. ++ model in the hippocampal slice preparation. Epilepsy Research 38 (2000) 53-66
6. Dost R., Rostock A., and Rundfeldt C. The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation. Naunyn-Schmiedeberg's Archives of Pharmacology 369 (2004) 382-390
7. Evans R.H. The pharmacology of segmental transmission in the spinal cord. Progress in Neurobiology 33 (1989) 255-279
8. Hedo G., and Lopez-Garcia J.A. Alpha-1A adrenoceptors modulate potentiation of spinal nociceptive pathways in the rat spinal cord in vitro. Neuropharmacology 41 (2001) 862-869
9. Hedo G., Laird J.M., and Lopez-Garcia J.A. Time-course of spinal sensitization following carrageenan-induced inflammation in the young rat: a comparative electrophysiological and behavioural study in vitro and in vivo. Neuroscience 92 (1999) 309-318
10. Hetka R., Rundfeldt C., Heinemann U., and Schmitz D. Retigabine strongly reduces repetitive firing in rat entorhinal cortex. European Journal of Pharmacology 386 (1999) 165-171
11. Jankowska E., McCrea D., Rudomin P., and Sykova E. Observations on neuronal pathways subserving primary afferent depolarization. Journal of Neurophysiology 46 (1981) 506-516
12. Jentsch T.J. Neuronal KCNQ potassium channels: physiology and role in disease. Nature Reviews Neuroscience 1 (2000) 21-30
13. Khasabov S.G., Lopez-Garcia J.A., and King A.E. Serotonin-induced population primary afferent depolarisation in vitro: the effects of neonatal capsaicin treatment. Brain Research 789 (1998) 339-342
14. Lopez-Garcia J.A., and King A.E. A novel methodology for simultaneous assessment of the effects of 5-hydroxytryptamine on primary afferent polarisation and synaptic transmission in rat dorsal horn neurones in vitro. Journal of Neuroscience Methods 68 (1996) 1-6
15. Lopez-Garcia J.A., and Laird J.M. Central antinociceptive effects of meloxicam on rat spinal cord in vitro. Neuroreport 9 (1998) 647-651
16. Nielsen A.N., Mathiesen C., and Blackburn-Munro G. Pharmacological characterisation of acid-induced muscle allodynia in rats. European Journal of Pharmacology 487 (2004) 93-103
17. Otto J.F., Kimball M.M., and Wilcox K.S. Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission. Molecular Pharmacology 61 (2002) 921-927
18. Passmore G.M., Selyanko A.A., Mistry M., Al-Qatari M., Marsh S.J., Matthews E.A., Dickenson A.H., Brown T.A., Burbidge S.A., Main M., and Brown D.A. KCNQ/M currents in sensory neurons: significance for pain therapy. The Journal of Neuroscience 23 (2003) 7227-7236
19. Price T.J., Cervero F., and de Koninck Y. Role of cation-chloride-cotransporters (CCC) in pain and hyperalgesia. Current Topics in Medicinal Chemistry 5 (2005) 547-555
20. Rees H., Sluka K.A., Westlund K.N., and Willis W.D. Do dorsal root reflexes augment peripheral inflammation?. Neuroreport 5 (1994) 821-824
21. Rivera-Arconada I., and Lopez-Garcia J.A. Effects of M-current modulators on the excitability of immature rat spinal sensory and motor neurones. The European Journal of Neuroscience 22 (2005) 3091-3098
22. Rivera-Arconada I., Martinez-Gomez J., and Lopez-Garcia J.A. M-current modulators alter rat spinal nociceptive transmission: an electrophysiological study in vitro. Neuropharmacology 46 (2004) 598-606
23. Rossignol S., Beloozerova I., Gossard J.P., and Dubuc R. Presynaptic mechanisms during locomotion. In: Rudomin P., Romo R., and Mendell L.M. (Eds). Presynaptic Inhibition and Neural Control (1998), Oxford University Press, New York 385-397
24. Rostock A., Tober C., Rundfeldt C., Bartsch R., Engel J., Polymeropoulos E.E., Kutscher B., Loscher W., Honack D., White H.S., and Wolf H.H. D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Research 23 (1996) 211-223
25. Rudomin P., and Schmidt R.F. Presynaptic inhibition in the vertebrate spinal cord revisited. Experimental Brain Research 129 (1999) 1-37
26. Rundfeldt C. The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells. European Journal of Pharmacology 336 (1997) 243-249
27. Rundfeldt C., and Netzer R. Investigations into the mechanism of action of the new anticonvulsant retigabine. Interaction with GABAergic and glutamatergic neurotransmission and with voltage gated ion channels. Arzneimittelforschung 50 (2000) 1063-1070
28. Shimizu T., Yoshimura M., Baba H., Shimoji K., and Higashi H. Role of A delta afferent fibers in modulation of primary afferent input to the adult rat spinal cord. Brain Research 691 (1995) 92-98
29. Tatulian L., Delmas P., Abogadie F.C., and Brown D.A. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. Journal of Neuroscience 21 (2001) 5535-5545
30. van Rijn C.M., and Willems-van Bree E. Synergy between retigabine and GABA in modulating the convulsant site of the GABAA receptor complex. European Journal of Pharmacology 464 (2003) 95-100
31. Wang H.S., Pan Z., Shi W., Brown B.S., Wymore R.S., Cohen I.S., Dixon J.E., and McKinnon D. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 282 (1998) 1890-1893
32. Willis W.D.J. Dorsal root potentials and dorsal root reflexes: a double-edged sword. Experimental Brain Research 124 (1999) 395-421
33. Yue C., and Yaari Y. KCNQ/M channels control spike after depolarization and burst generation in hippocampal neurons. The Journal of Neuroscience 24 (2004) 4614-4624
34. Zaczek R., Chorvat R.J., Saye J.A., Pierdomenico M.E., Maciag C.M., Logue A.R., Fisher B.N., Rominger D.H., and Earl R.A. Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdine. The Journal of Pharmacology and Experimental Therapeutics 285 (1998) 724-730